Serum MG53 as a diagnostic marker for tissue injury
US8420338B2 · kind B2 · utility
3Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2011 |
| Grant date | Apr 16, 2013 |
| Priority date | — |
| Expiry date | Nov 5, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6887
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein are compositions and methods for measuring the level of MG53 found in a biological fluid as a biomarker for a disease or disorder, e.g., tissue damage, exercise capacity or a muscle-related disease or disorder. In addition, the invention relates to targeting the native MG53 found in the blood as a therapeutic approach.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.